Aptuit has increased its global capacity for API manufacture, opening of a 1600L/1000L reactor stream at its API facility in Oxford, UK and increasing throughput for 400L reactors at its fully integrated, former large Pharma R&D center of excellence in Verona, Italy. Aptuit’s strategy aims to allow increased throughput of integrated development programs, as well as deliver standalone API at 40-120 kg batch scale for early to mid-stage clinical trials.    Dr. Goldman chief executive off...